Open AccessEndophthalmitis prophylaxis in cataract surgery: Overview of current practice patterns in 9 European countries
Author(s) -
Anders Behndig,
Béatrice Cochener,
José L. Gϋell,
Laurent Kodjikian,
Rita Mencucci,
Rudy M.M.A. Nuijts,
Uwe Pleyer,
Paul Rosen,
Jacek P. Szaflik,
MarieJosé Tassig
Publication year - 2013
Publication title -
journal of cataract and refractive surgery/journal of cataract and refractive surgery
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.678
H-Index - 142
eISSN - 1873-4502
pISSN - 0886-3350
DOI - 10.1016/j.jcrs.2013.06.014
Subject(s) - cefuroxime , medicine , endophthalmitis , cataract surgery , asepsis , perioperative , antibiotic prophylaxis , optometry , intensive care medicine , antibiotics , surgery , ophthalmology , microbiology and biotechnology , biology
Data on practice patterns for prophylaxis against infectious postoperative endophthalmitis (IPOE) during cataract surgery in 9 European countries were searched in national registers and reviews of published surveys. Summary reports assessed each nation's IPOE rates, nonantibiotic prophylactic routines, topical and intracameral antibiotic use, and coherence to the European Society of Cataract & Refractive Surgeons (ESCRS) 2007 guidelines. Although the reliability and completeness of available data vary between countries, the results show that IPOE rates differ significantly. Asepsis routines with povidone-iodine and postoperative topical antibiotics are generally adopted. Use of preoperative and perioperative topical antibiotics as well as intracameral cefuroxime varies widely between and within countries. Five years after publication of the ESCRS guidelines, there is no consensus on intracameral cefuroxime use. Major obstacles include legal barriers or persisting controversy about the scientific rationale for systematic intracameral cefuroxime use in some countries and, until recently, lack of a commercially available preparation.